Cassandra S.L. Ho

Statistics

Publications

Citations

118

H-Index

Active since

2012

Affiliations

Essen University Hospital(Current)

Deutsches Konsortium für Translationale Krebsforschung

Ruhrlandklinik

Cassandra S.L. Ho is an author at Essen University Hospital specializing in oncogenes, tyrosine kinase inhibitors, and receptor tyrosine kinase oncogenes.

ORCID

Publications per year

2012–2021

Publications

Persistent Helicobacter pylori Specific Th17 Responses in Patients with Past H. pylori Infection Are Associated with Elevated Gastric Mucosal IL-1β

Victoria Serelli-Lee, Khoon Lin Ling, Cassandra S.L. Ho et al. · PLoS ONE · 2012 · 52 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

HER2 mediates clinical resistance to the KRASG12C inhibitor sotorasib, which is overcome by co-targeting SHP2

Cassandra S.L. Ho, Alicia I. Tüns, Hans‐Ulrich Schildhaus et al. · European Journal of Cancer · 2021 · 46 citations

Medicine, Cancer Biology, Molecular Biology +13

HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma model

Paul Stockhammer, Cassandra S.L. Ho, Luca Hegedüs et al. · Lung Cancer · 2020 · 20 citations

Medicine, Oncology, Pharmacology +17

1–3 of 3